Literature DB >> 23133025

Temporal artery biopsy: impact on the clinical management of patients.

M Sintler1, A Garnham, A Mahmood, D Rittoo, H S Khaira, R K Vohra.   

Abstract

OBJECTIVES: Temporal artery biopsy (TAB) is requested in an attempt to confirm the diagnosis of temporal arteritis (TA). Patients symptoms and signs are highly variable and TA is often focal and potentially missed in a small biopsy. The study aimed to determine if TAB helps in the management of patients with suspected TA.
METHODS: The case records of sixty-six consecutive patients who had undergone temporal artery biopsy were recalled and examined for presenting symptoms, management, therapy, results and outcome.
RESULTS: There were 23 men and 43 women with a mean age of 70.2 and 71.1 years respectively. Presenting symptoms varied with unilateral headache in 53, scalp tenderness in 16, muscle weakness in 10, visual disturbance in 16, jaw claudication in 5 and peri-orbital pain in 1 patient. The temporal artery was tender in 21 patients and thickened in 4 patients. Thirty-eight patients were commenced on steroids prior to biopsy and 6 more before the histology became available. Only 8% of biopsies were positive for TA. Of the patients started on steroids with a negative biopsy, the steroids were continued in 26 and stopped in 9. In the patients not put on steroids [22], biopsy was positive in 2; they were commenced on steroids. Therefore, the histological diagnosis resulted in a change in patient management in only 18% of patients.
CONCLUSION: The results of TAB do not appear to affect the clinical management of most patients with suspected temporal arteritis. We must therefore question the routine use of this invasive investigation.

Entities:  

Year:  2008        PMID: 23133025      PMCID: PMC3452393          DOI: 10.1007/s12262-008-0019-7

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  21 in total

1.  Steroid therapy for visual loss in patients with giant-cell arteritis.

Authors:  S S Hayreh
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

2.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

Review 3.  Giant cell (temporal) arteritis.

Authors:  G G Hunder
Journal:  Rheum Dis Clin North Am       Date:  1990-05       Impact factor: 2.670

4.  Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Oral prednisolone 40 mg daily is not adequate for temporal arteritis once vision is affected.

Authors:  R Finlay
Journal:  BMJ       Date:  1997-08-30

5.  Color duplex ultrasonography in the diagnosis of temporal arteritis.

Authors:  W A Schmidt; H E Kraft; K Vorpahl; L Völker; E J Gromnica-Ihle
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

Review 6.  Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica.

Authors:  C R Hamilton; W M Shelley; P A Tumulty
Journal:  Medicine (Baltimore)       Date:  1971-01       Impact factor: 1.889

7.  The therapeutic impact of temporal artery biopsy.

Authors:  S Hall; S Persellin; J T Lie; P C O'Brien; L T Kurland; G G Hunder
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

8.  Temporal artery biopsy.

Authors:  M C Allison
Journal:  BMJ       Date:  1988-10-15

9.  Skip lesions in temporal arteritis.

Authors:  R G Klein; R J Campbell; G G Hunder; J A Carney
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

10.  The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

Authors:  M E Ellis; S Ralston
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.